
INVENTIVA S.A. ADR
Depository Receipt · US46124U1079 · IVA · A2P796 (XNAS)
3,61 USD
06.06.2025 19:12
Current Prices from INVENTIVA S.A. ADR
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
IVA
|
USD
|
06.06.2025 19:12
|
3,61 USD
| 3,41 USD
+5,72 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 6,34 % | 2,41 % | 15,92 % | 36,04 % | 1,84 % | -73,14 % |
Company Profile for INVENTIVA S.A. ADR Depository Receipt
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.
Company Data
Name INVENTIVA S.A. ADR
Company Inventiva S.A.
Symbol IVA
Website
https://www.inventivapharma.com
Primary Exchange
NASDAQ

WKN A2P796
ISIN US46124U1079
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Mr. Frederic Cren
Market Capitalization 322 Mio
Country France
Currency USD
Employees 0,1 T
Address 50 rue de Dijon, 21121 Daix
IPO Date 2020-07-10
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 6IVA.F |
NASDAQ | IVA |
More Shares
Investors who INVENTIVA S.A. ADR hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.